Your browser does not support JavaScript! Resources | Biofidelity

Resource Center

Webinars

Aspyre® Clinical Test for Lung: a rapid alternative to Comprehensive Genomic Profiling

Hear experts address the gaps and limitations of CGP by using innovative simplified genomic profiling solutions that work for challenging samples not analyzable by CGP.
Case Studies

Challenges in molecular testing: overcoming sample limitations in NSCLC

This case illustrates the significant advantages of using Biofidelity’s Aspyre Clinical Test for Lung in managing NSCLC.
Case Studies

Assessing NGS: Pleural fluid cell block with limited tumor content and NGS challenges

This case illustrates the significant advantages of using Biofidelity’s Aspyre Clinical Test for Lung in managing NSCLC.
Blog Posts

Beyond ALK & EGFR: Shifting the treatment paradigm of early-stage NSCLC

A new study from Biofidelity is examining how its Aspyre technology can bridge the gaps in clinical care that prevent early-stage NSCLC patients from receiving molecular profiling.
Videos

Aspyre Lung workflow

See the workflow for Aspyre Lung in the video below.
Videos

Aspyre Clinical Test workflow

See the workflow for Aspyre Clinical Test in the video below.
Product Information

Aspyre Lung product information

Fast, simple, decentralized testing for NSCLC biomarkers.
Product Information

Aspyre Clinical Test product information

Simple, fast, reliable detection of NSCLC biomarkers from tissue or blood within 2 days.
Blog Posts

ASCO 2024 workshop seeks to answer a burning question

Biofidelity's VP of Strategic Marketing, Anjana Bhattacharya, shares her thoughts from an ASCO 2024 workshop seeking to answer a burning question.